Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Senthilkumar Damodaran"'
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Activation of FGFR signaling through mutations, amplifications, or fusions involving FGFR1, 2, 3, or 4 is seen in multiple tumors, including lung, bladder, and cholangiocarcinoma. Currently, several clinical trials are evaluating the role of novel FG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e21686828eb56109db6f049a67750f
https://doi.org/10.1158/1535-7163.c.6538800
https://doi.org/10.1158/1535-7163.c.6538800
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Heat maps show RPPA protein changes in pair-matched control and BGJ398-resistant cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1372e4046339a814e6820e8d7ad5ec
https://doi.org/10.1158/1535-7163.22507830.v1
https://doi.org/10.1158/1535-7163.22507830.v1
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Supplemental Table 1. Expression of FGFR1 and FGFR3 in different cell lines; Supplemental Table 2. Normalized Reverse Phase Protein Array Results for DMS114; Supplemental Table 3. Normalized Reverse Phase Protein Array Results for RT112; Supplemental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe23a1ab4c50d46d2da9d0726f4769c
https://doi.org/10.1158/1535-7163.22507821
https://doi.org/10.1158/1535-7163.22507821
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
Chemical structures of inhibitors of FGFR (BGJ398) and Akt (GSK2141795).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d565f0bdd16ecc17a65dbf6c214f01
https://doi.org/10.1158/1535-7163.22507842
https://doi.org/10.1158/1535-7163.22507842
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
FGFR 1 and FGFR3 expression in DMS114 and RT112 cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297c13c73ff81ade85ab5a0d4165770e
https://doi.org/10.1158/1535-7163.22507845
https://doi.org/10.1158/1535-7163.22507845
Autor:
Sameek Roychowdhury, Julie W. Reeser, John Hays, Darshna Bhatt, Michele R. Wing, Eric Samorodnitsky, Elijah P. Gardner, Lianbo Yu, Jharna Miya, Cristina Ocrainiciuc, Hannah Parks, Senthilkumar Damodaran, Jharna Datta
MAPK signaling pathway in BGJ398 resistant cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b23ed94c278aad0115bafa5794dc61b
https://doi.org/10.1158/1535-7163.22507824
https://doi.org/10.1158/1535-7163.22507824
Autor:
Funda Meric-Bernstam, Richard B. Lanman, Victoria M. Raymond, David R. Fogelman, Siqing Fu, Vivek Subbiah, David S. Hong, Ahmed O. Kaseb, Milind Javle, Senthilkumar Damodaran, Cathy Eng, Kenna R. Mills Shaw, Nora S. Sanchez, Filip Janku, Kenneth R. Hess, Seyed Pairawan
Purpose:Physicians are expected to assess prognosis both for patient counseling and for determining suitability for clinical trials. Increasingly, cell-free circulating tumor DNA (cfDNA) sequencing is being performed for clinical decision making. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ee9b38a61be4759a2148759564c81ec
https://doi.org/10.1158/1078-0432.c.6528630.v1
https://doi.org/10.1158/1078-0432.c.6528630.v1
Autor:
Jeffrey T. Chang, Stacy L. Moulder, Lei Huo, Rosalind P. Candelaria, Gaiane M. Rauch, Elizabeth A. Mittendorf, Alistair M. Thompson, Gabriel N. Hortobagyi, Aman U. Buzdar, Xiaoxian Li, Luis Baez, Bora Lim, Rashmi K. Murthy, Naoto T. Ueno, Jennifer K. Litton, Banu K. Arun, Senthilkumar Damodaran, Debu Tripathy, Vicente Valero, Alyson R. Clayborn, Elizabeth E. Ravenberg, Jason B. White, Qing-Qing Ding, Beatriz E. Adrada, Ryan Sun, Nour Abuhadra, Clinton Yam
Supplementary Figure from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::031d63d3a2dd436e50408dd615422603
https://doi.org/10.1158/1078-0432.22487816.v1
https://doi.org/10.1158/1078-0432.22487816.v1
Autor:
Funda Meric-Bernstam, Richard B. Lanman, Victoria M. Raymond, David R. Fogelman, Siqing Fu, Vivek Subbiah, David S. Hong, Ahmed O. Kaseb, Milind Javle, Senthilkumar Damodaran, Cathy Eng, Kenna R. Mills Shaw, Nora S. Sanchez, Filip Janku, Kenneth R. Hess, Seyed Pairawan
Supplemental Tables 1, 2, 3 and Supplemental Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b3ff47c46e9ddec611cb429fe2acca
https://doi.org/10.1158/1078-0432.22473903
https://doi.org/10.1158/1078-0432.22473903
Autor:
Jeffrey T. Chang, Stacy L. Moulder, Lei Huo, Rosalind P. Candelaria, Gaiane M. Rauch, Elizabeth A. Mittendorf, Alistair M. Thompson, Gabriel N. Hortobagyi, Aman U. Buzdar, Xiaoxian Li, Luis Baez, Bora Lim, Rashmi K. Murthy, Naoto T. Ueno, Jennifer K. Litton, Banu K. Arun, Senthilkumar Damodaran, Debu Tripathy, Vicente Valero, Alyson R. Clayborn, Elizabeth E. Ravenberg, Jason B. White, Qing-Qing Ding, Beatriz E. Adrada, Ryan Sun, Nour Abuhadra, Clinton Yam
Purpose:Metaplastic breast cancer (MpBC) is a rare subtype of breast cancer that is commonly triple-negative and poorly responsive to neoadjuvant therapy in retrospective studies.Experimental Design:To better define clinical outcomes and correlates o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5a5c1b653f1a2a1baf688e0d7014e2
https://doi.org/10.1158/1078-0432.c.6532592.v1
https://doi.org/10.1158/1078-0432.c.6532592.v1